Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.
- 1 April 1984
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 81 (7), 2075-2079
- https://doi.org/10.1073/pnas.81.7.2075
Abstract
The tumor promoter phorbol 12-myristate 13-acetate (PMA) reversibly inhibits hexamethylene bisacetamide-induced terminal differentiation of Friend erythroleukemia cells (FELC). We were successful in continuously inhibiting FELC differentiation by PMA up to 125 weeks (about 240 serial passages of cells in the presence of PMA). During that period, FELC can be induced to differentiate and enter terminal cell division upon removal of PMA. PMA-mediated suppression of FELC differentiation was associated with only a low level of globin mRNA accumulation. However, a rapid accumulation of globin mRNA in the cytoplasm followed by hemoglobin accumulation occurred upon removal of PMA. A specific, saturable, high-affinity receptor for phorbol esters is present in FELC, as was shown by binding studies with [3H]phorbol 12,13-dibutyrate. A significant (80%) loss in the number of phorbol ester receptors of FELC was observed after a continuous inhibition of differentiation by PMA for as much as 125 weeks. Despite such a down regulation of phorbol ester receptors, these cells respond to PMA with a dose-response similar to that of their parent cells, which have the normal number of phorbol ester receptors. Thus, PMA can suppress reversibly the accumulation of globin-specific mRNA and terminal differentiation of FELC during prolonged periods, despite loss of receptor sites, and our results suggest that only few phorbol ester receptors may be necessary for complete inhibition of FELC differentiation by PMA.Keywords
This publication has 29 references indexed in Scilit:
- Identification of a calcium- and phospholipid-dependent phorbol ester binding activity in the soluble fraction of mouse tissuesBiochemical and Biophysical Research Communications, 1983
- Binding of phorbol esters to high‐affinity sites on murine fibroblastic cells elicits a mitogenic responseJournal of Cellular Physiology, 1982
- Specific binding of phorbol esters to Friend erythroleukemia cells — general properties, down regulation and relationship to cell differentiationCarcinogenesis: Integrative Cancer Research, 1982
- The down-modulation of receptors for phorbol ester tumor promoter in primary epidermal cellsCarcinogenesis: Integrative Cancer Research, 1982
- Modulation of Globin Gene Expression by a Tumor Promoter during Induced Differentiation of Friend Erythroleukemic CellsEuropean Journal of Biochemistry, 1981
- Specific binding of phorbol ester tumor promoters to mouse skinCell, 1980
- Tumor promoters: Effects on proliferation and differentiation of cells in cultureLife Sciences, 1978
- The expression of viral and globin genes during differentiation of the friend cellExperimental Cell Research, 1977
- Tumour promotor induces plasminogen activatorNature, 1976
- Kinetic studies of gene frequency: I. Use of a DNA copy of reticulocyte 9 S RNA to estimate globin gene dosage in mouse tissuesJournal of Molecular Biology, 1974